Reviva Pharmaceuticals Holdings
Stock Forecast, Prediction & Price Target

Reviva Pharmaceuticals Holdings Financial Estimates

Reviva Pharmaceuticals Holdings Revenue Estimates

Reviva Pharmaceuticals Holdings EBITDA Estimates

Reviva Pharmaceuticals Holdings Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $220.44M
Low: $220.44M
High: $220.44M
avg. 0%
Avg: $137.29M
Low: $137.29M
High: $137.29M
avg. -37.71%
Avg: $249.43M
Low: $249.43M
High: $249.43M
avg. 81.67%
Net Income
 
% change YoY
$-8.52M
 
N/A
$-24.33M
 
-185.60%
$-39.26T
 
-161306305.29%
Avg: $-48.33M
Low: $-20.88M
High: $-13.85M
avg. 99.99%
Avg: $-39.33M
Low: $-19.90M
High: $-5.07M
avg. 18.62%
Avg: $13.07M
Low: $13.07M
High: $13.07M
avg. 133.24%
Avg: $37.08M
Low: $37.08M
High: $37.08M
avg. 183.58%
EBITDA
 
% change YoY
$-10.10M
 
N/A
$-24.11M
 
-138.62%
$-39.50T
 
-163834511.28%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.58
 
N/A
-$1.25
 
-115.51%
-$1.65
 
-31.99%
Avg: -$0.89
Low: -$1.07
High: -$0.71
avg. 46.21%
Avg: -$0.64
Low: -$1.02
High: -$0.26
avg. 27.88%
Avg: $0.67
Low: $0.67
High: $0.67
avg. 204.68%
Avg: $1.9
Low: $1.9
High: $1.9
avg. 183.58%
Operating Expenses
 
% change YoY
$10.10M
 
N/A
$24.30M
 
140.55%
$39.50T
 
162522107.95%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Reviva Pharmaceuticals Holdings stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 108.86% in 2025-2028.

We have gathered data from 3 analysts. Their low estimate is -20.88M, average is -48.33M and high is -13.85M.

What is Reviva Pharmaceuticals Holdings stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 10.99% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Reviva Pharmaceuticals Holdings stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 115.59% in 2025-2028.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.07, average is -$0.89 and high is $-0.71.

What is the best performing analyst?

In the last twelve months analysts have been covering Reviva Pharmaceuticals Holdings stock. The most successful analyst is Raghuram Selvaraju.